New immunotherapy targets genetic flaw in rare childhood cancers
Disease control
Not yet recruiting
This study tests a new immunotherapy designed to help the immune system recognize and attack cancer cells in people with high-risk Ewing sarcoma or desmoplastic small round cell tumor (DSRCT). The treatment targets a specific genetic change found only in these cancer cells, aimin…
Phase: PHASE1 • Sponsor: Rabi Hanna • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC